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OBJECTIVE: Xenon provides neuroprotection in multiple animal models however 
little is known about the other noble gases. The aim of the current study was to 
compare xenon, argon and helium neuroprotection in a neonatal asphyxia model in 
rats.  
DESIGN: Randomized controlled trial. 
SETTING: Laboratory. 
SUBJECTS: Seven day old postnatal Sprague-Dawley rats.  
INTERVENTIONS: 70% argon, helium, xenon or nitrogen balanced with oxygen 
following hypoxic-ischemic brain injury.  
MEASUREMENTS AND MAIN RESULTS: Control animals undergoing moderate 
hypoxic-ischemia endured reduced neuronal survival at 7 days with impaired 
neurological function at the juvenile age compared with naïve animals. Severe 
hypoxic-ischemic damage produced a large cerebral infarction in controls. Following 
moderate hypoxic-ischemia, all three noble gases improved cell survival, brain 
structural integrity and neurological function on post-natal day 40 compared to 
nitrogen. Interestingly argon improved cell survival to naïve levels while xenon and 
helium did not. When tested against more severe hypoxic-ischemic injury only, argon 
and xenon reduced infarct volume. Furthermore post-injury body weight in moderate 
insult was lower in the helium treated group compared to the naïve, control and 
other noble gas treatment groups while in severe injurious setting it is lower in both 
control and helium treated group than other groups. In the non-directly injured 
hemisphere argon, helium and xenon increased the expression of Bcl-2 while helium 
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and xenon increased Bcl-xL. In addition, Bax expression was enhanced in the control 
and helium groups.  
CONCLUSIONS: These studies indicate that argon and xenon provide neuroprotection 
against both moderate and severe hypoxia-ischemic brain injury likely via prosurvival 
proteins synthesis.  
 




Perinatal hypoxic-ischemic encephalopathy (HIE) endures a high mortality with 
20-40% of the survivors having severe neuropsychological impairment (1-3). The 
effect on patient quality of life and the social and financial burden incurred are 
significant warranting research into novel neuroprotective strategies. Hypothermia is 
now an established neuroprotective therapeutic for HIE (2, 4-6) although the 
neuroprotection is far from absolute with approximately half of patients still 
enduring neurological sequelae. Combination strategies are therefore required to 
augment hypothermic neuroprotection.  
 
The noble gas xenon has demonstrated organoprotective properties when 
administered alone (7-14) or in combination with hypothermia (15-18). Similar to 
xenon, argon and helium have shown neuroprotective qualities in vitro (11-14) and in 
vivo (13, 19) while other members of noble gas family, neon and krypton, lack effect 
(11). Interestingly helium has also been reported to exhibit both detrimental as well 
as protective effects (11-13). However, a study to comparing the neuroprotective 
potency of these three gases argon, helium and xenon in vivo is not available to 
date.  
 
There are notable differences between the three noble gases. Xenon is an anesthetic 
at atmospheric pressure, argon and helium are not, making their potential roles and 
side effects very different. Furthermore compared with the scarceness and excessive 
cost of xenon, helium and argon are relatively inexpensive. Despite these differences 
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some important core attributes are shared: good blood-brain barrier penetration 
and fast onset making them good candidates for neuroprotection. Our aim herein 
was to compare the neuroprotective effects of argon, helium and xenon against 
brain injury in a model of neonatal asphyxia in rats. Ultimately, we wish to identify 
the best candidate noble gas to treat HIE patients.  
 
Materials and Methods: 
The study protocol was approved by the Home Office (United Kingdom), and all 
efforts were made to minimize the animals’ suffering and the number of animals 
used to detect a difference of at least 30% between the control and the trial arm. 
Sprague-Dawley rat pups were used for experiments. Twelve pups with their mother 
were used and housed with a 12-hour light/dark schedule in a temperature and 
humidity controlled colony room. The pups were housed with their dams until 
weaning on postnatal Day 21 (PND 21), and then were housed in groups of four per 
cage based on different sex. 
 
Animal Model of Neonatal Asphyxia 
Seven day old postnatal Sprague-Dawley rats underwent right common carotid 
artery ligation under surgical anesthesia (2% isoflurane) as reported previously (9) . 
After ligation, the animals were returned to their dams at a constant temperature 
(23°C) and humidity (48%) for recovery. One hour after surgery, neonatal rats were 
placed in purpose-built multi-chambers in which 8% O2 balanced with N2 was 
supplied continuously for 90 minutes or 120 min. The body temperature was 
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maintained by submerging the exposure chambers into a water bath as reported 
previously (15). The experimental protocol is presented in Fig. 1. Two hours after 
hypoxic insult, animals were randomly exposed to either argon, helium, xenon (70% 
noble gas balanced with O2) or nitrogen (known as control group, 70% N2 balanced 
with O2) for 90 minutes, using a purpose-built, closed-circle delivery system which 
was made up with six multi-chambers, one gas reservoir bag and one gas monitor 
with a built in gas pump. The total volume of the system is about 3.5 L. The system 
was flushed with more than 4 times of system volume of the mixed gases before the 
closed gas delivery circle system was established. Soda lime and silica gel (Merck, 
Leicestershire, United Kingdom) was used in the chambers to eliminate carbon 
dioxide and water generated by animals. The mixed gases were refilled into the 
system for every 20-30 min to compensate the gas lost from the system. Gas 
concentration of oxygen was measured continuously by an in-line gas analyzer (Air 
Products Model No. 439Xe). Other cohort of untreated pups were included as naïve 
group (n = 30). 
 
Determination of Cell Survival In Vivo 
Seven days after receiving 90 min hypoxic insult (n = 5/group) or 14 days after 
receiving 120 min hypoxic insult (n = 7/group), rats were anesthetized with sodium 
pentobarbital (100 mg/kg, intraperitoneally) and perfused transcardially with 
paraformaldehyde (4%) in phosphate buffer (PB) (0.1 M). The brains were removed 
and placed in 4% paraformaldehyde in 0.1 mol/L PB overnight. The blocks of brain 
were dehydrated, embedded in wax, sectioned into 5 mm slices and then stained 
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with 0.5% cresyl violet. The coronal sections (5 mm) from rats received 90 min 
hypoxic insult were harvested around -3.6 mm bregma relative to adult brain. The 
CA1 area of the hippocampus from the bilateral side of each brain was chosen for 
data analysis and the microphotograph was taken at 40X using a BX-60 light 
microscope (Olympus, Southall, United Kingdom) attached with a digital camera 
(Zeiss, Gottingen, Germany). The total number of healthy cells that appeared in the 
CA1 area of hippocampus in cresyl violet staining slices was counted from 4 
sections/brain in a blind manner (T.Y.) and their mean value was used for data 
analysis.  
 
The following morphological criteria were used to analyze apoptotic or necrotic cell 
death in cerebral CA area of hippocampus. Viable cells were regularly shaped with 
pale cytoplasm and a clearly visible, darker nucleus (Fig 2A). Apoptotic cells had dark 
stained, shrunken nuclei that were spherically shaped and an intact cell membrane, 
often with a surrounding area of vacuolation (20). Necrotic cells were identified by 
intense cresyl violet staining of the cytoplasm with irregularly shaped, enlarged nuclei 
and loss of nuclear membrane integrity (21). 
 
The coronal sections (5 mm) from rats received 120 min hypoxic insult were selected 
from each pup to match predefined brain regions relative to the bregma (+2 mm, +1, 
0, -2, -4 and –5) relative to adult brain. Once identified, each slice was photographed 
and the size (arbitrary unit) of the healthy matter of both hemispheres was calculated 
with data analysis software (ImageJ v1.31, NIH image software, USA) by one author 
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who was blinded to the treatment that the pups had received. The infarction size was 
calculated with a formula of (left hemisphere – right hemisphere)/left hemisphere 
(%). Then the data were used to plot curves and the area under curve was calculated 
to indicate the infarction volume (arbitrary unit).   
 
Neurologic Function Assessment 
Other cohorts with 90 min hypoxic insult were allowed to live up to PND 49 days 
after the experiments for neurologic functional test. The body weight of each rat was 
recorded before following behavior assessments. 
 
Rotarod test 
Animals (n = 6/group) underwent rotarod test according to an established protocol 
(22). Motor function was tested by placing rats on a 2.5 cm diameter plastic rod, 
rotating at 30 r.p.m. (rounds per minute) and 50 r.p.m. on the next day, and the 
latency to fall off the rod was assessed (maximal latency was 300 seconds). The 
apparatus was set up in an environment with minimal stimuli such as noise, 
movement or changes in light or temperature. For each of the functional assay, the 
rat was tested three times with a 10 minute interval between each assessment, and 
the mean value of three assessments was used for each rat in the analysis. The 






Morris Water Maze (WM) 
After rotarod test, neurocognitive outcome was evaluated daily (starting from PND 
40) using Morris water maze (WM) by using a computerized video tracking system 
(EthoVision®; Noldus, Wageningen, The Netherlands) (n = 6/group). Briefly, WM 
consisted of a circular pool 110 cm in diameter and 60 cm in height, filled to a depth 
of 30 cm with water (24 ± 0.5°C). A hidden submerged platform was placed in one 
quadrant 2.5cm below water surface. Rats were placed in the water in a dimly lit 
room with visual clues around room wall. The time of locating the submerged 
platform (defined as the latency and cut off time 90 sec) was measured. The longer 
time required to locate the platform indicates the more impairment in spatial 
learning and memory. Four trials of testing were performed for each rat everyday. 
Each trial started from a different quadrant. Testing was consecutively repeated for 5 
days.  
 
Western Blot Analysis 
Rats were killed under pentobarbitone anesthesia two hours after gas exposure (n = 
5/group). Left hemispheres were harvested separately, lysed in lysis buffer (pH 7.5, 
20 mmol/L Tris-HCl, 150 mmol/L NaCl, 1 mmol/L Na2DTA, 1 mmol/L EGTA, 1% Triton, 
2.5 mmol/L sodium pyrophosphate, 1 mmol/L β-glycerophosphate, 1 mmol/L 
Na3VO4, 2 mmol/L DL-dithiothreitol, 1 mmol/L phenylmethanesulphonyl and 1 
ug/ml leupeptin), and centrifuged at 3,000g for 30 mins. Protein concentration in the 
supernatant was determined by Dc protein assay (Bio-Rad, Herts, UK). Protein 
extracts (30 ug/sample) and a biotinylated molecular weight marker (New England 
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Biolab, Hitchin, UK) were denatured in Laemmli sample loading buffer (Bio-Rad, 
Herts, UK) at 100°C for 5 mins, separated by 10.5% sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 
nitrocellulose membrane (Amersham Biosciences, Little Chalfont, UK). The 
membrane was treated with blocking solution (5% nonfat dry milk in 
Tween-containing Tris-buffered saline (10mmol/L Tris, 150mmol/L NaCl, 0.1% Tween, 
pH 8.0)) and incubated with rabbit monoclonal antibody directed against Bax (1:1500; 
Delta Biolabs, Cambridge, United Kingdom), Bcl-xL (1:1000, Cell Signaling Technology, 
Danvers, USA), Bcl-2 (1:500, Cell Signaling Technology, Danvers, USA) or mouse 
monoclonal antibody against α-tubulin (1:2000, Sigma, Poole, UK) overnight at 4°C. 
The horseradish peroxidase-conjugated goat antibody to rabbit or mouse IgG 
(1:1000, New England Biolab, Hitchin, UK) was used to detect the primary antibodies. 
The bands were visualized with the enhanced chemiluminescence system (ECL, 
Amersham Biosciences, Little Chalfont, UK) and intensities were quantified by 
densitometry. Results were normalized with α-tubulin. 
 
Statistical Analysis 
Data are expressed as mean +/- SD or box-and-whisker plot. The significance of 
differences was determined by analysis of variance (ANOVA) followed by 
Newman-Keuls test or Mann–Whitney test wherever appropriate. A value p < 0.05 






No pups died during or after the 90 minute hypoxic insult but following the 120 
minute hypoxic insult 3 and 4 pups died respectively in the helium and nitrogen gas 
treatment groups.  
 
Cell Viability in the Hippocampus 
Healthy cells in both right and left CA area of hippocampus were readily to be seen in 
naïve animals (Fig 2A). No differences in viable cell count were observed in the left 
hemisphere (F = 1.7; P=0.16). The thickness of healthy layer in the right CA area (that 
underwent hypoxic-ischemic injury) of the control group was significantly reduced 
when compared with that of naïve, argon, helium and xenon group (Fig 2B). 
Quantitative analysis revealed that argon, helium and xenon treatment significantly 
increased the healthy cell number of cells in the right CA area of hippocampus from 
37 ± 8 in control group to 54 ± 6, 48 ± 5 and 47 ± 5 respectively (F= 25; P < 0.001). 
Argon treatment restored the cell number to that of naïve rats while that number of 
viable cells in the xenon and helium was still reduced compared to the naïve and 
argon groups (P < 0.001) (Fig 2F). 
 
Infarction size 
We then determined whether the protective profile is also evident following severe 
insult (with 120 min hypoxia). Xenon and Argon significantly decreased infarction 
volume by 42% (F = 4.4, p < 0.05) and 38% (p < 0.05) when compared to control. 




Neurological Function and Body Weight 
Hypoxic (for 120 min) -ischemic injury reduced the body weight on PND 21 from 39 ± 
2 g (naïve) to 33 ± 1.3 g (control) (p < 0.01) and 30 ± 3.9 g (helium) (F = 22; P < 0.0001) 
(Fig 4A). Hypoxic-ischemic injury for 90 min reduced the body weight on PND 38 
from 123 ± 20 g (naïve) to 110 ± 7 g (control). However in the helium group the body 
weight was further reduced to 85 ± 12 g (F = 6.6; P= 0.0009). There was no significant 
difference between the body weight of argon, xenon and control group (Fig 4B). 
 
On PND 38 the animals underwent neurological testing. There was no difference 
between the five groups when motor function was tested at 30 rpm (F = 0.7; p = 
0.5996; Fig 5A) or 50 rpm (F = 2.5; p = 0.0774; Fig 5B). 
 
On PND 40 neurological function was tested in the Morris Water maze. The line graph 
showed that the latencies to find the platform of five groups were similar on the first 
day. All the groups, except the control group, showed gradually reduced latency in 
following four days (Fig 6A). We used the area under curve (AUC) to denote the 
cumulative time of four trials based on the five testing day. There was a significant 
difference between noble gas groups and control group (F = 8.2; P = 0.0002; Fig 6B). 
There was no difference in the average swimming speed between groups (Fig 6C). 
 
Bax, Bcl-2 and Bcl-xL 
Apoptotic cell death induced by ischemia/hypoxia insult in neonates is mediated via 
the intrinsic (mitochondrial) pathway (23). We chose Bax, Bcl-2 and Bcl-xL as target 
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proteins to examine whether they were involved mechanistically in the 
neuroprotection effect provided by noble gases. Bax, Bcl-2 and Bcl-xL exert pivotal 
roles in apoptosis; Bax promotes cell death and latter two promote survival. Because 
the right hemisphere is injured, the effects of gas treatment on protein expression 
can be distorted. We, therefore, chose to investigate these protein expression in the 
left hemisphere following gas exposure. Two hours after gas exposure, Bax 
expression was enhanced in the control and helium groups (F = 2.7; p = 0.0624; Fig 
7A) although it did not reach to a statistical significance. Bcl-xL expression was 
increased by helium and xenon in comparison with control and naïve groups (F = 5.9; 
p = 0.0025; Fig 7B). Bcl-2 expression was significantly increased by argon compared 
with control and naïve groups and increased to lesser degree by helium and xenon (F 
= 5.7; P = 0.003; Fig 7C).  
 
Discussion: 
There are five major findings from our work: (i) Argon, helium and xenon treatment 
significantly restored the cell morphology from mild ischemic/hypoxic insult, though 
only argon restored cell viability to naïve levels; (ii) Argon and xenon treatment 
reduced infarct volume from severe ischemia but helium did not; (iii) Neurological 
function assessed with Morris Water maze was improved in all noble gases treated 
groups; (iv) Animals treated with helium had reduced body weight compared to the 
other groups; (v) The neuroprotection afforded by these three gases was associated 
with increased Bcl-2 levels while xenon and helium were also associated with 




It is intriguing that the so called “inert” noble gases attract attention as putatively 
organ-protective agents; indeed the most widely studied, xenon, shows protective 
effects in vitro and in vivo in several different organs (7-9, 11, 12). We have repeated 
our observation that xenon is a potent neuroprotective agent in this model and 
extended these findings to include evidence that long-term neurocognition, 
measured by the Morris Water maze, is enhanced by xenon therapy. However our 
aim was to compare the different noble gases to discern whether cheaper 
alternatives to xenon may be identified. Therefore it is of interest that in our study, 
argon and xenon showed comparable neuroprotection with more healthy cells in 
hippocampus, reduced infarct volume and long-term maintenance of brain tissue 
integrity and neurological function. Furthermore argon was the only noble gas able 
to restore the viable cell counts to naïve levels. In contrast while helium was 
protective against 90 minutes of hypoxic-ischemia, its protection was lost against a 
more severe insult of 120 minutes of hypoxic-ischemia. 
 
Argon has also been shown to exert significant neuroprotective effect in in vitro 
models of injury and in an adult model of hypoxic-ischemic injury in vivo (11, 14). As 
far as we are aware this is the first report describing argon neuroprotection against 
hypoxic-ischemic injury in young animals. Furthermore this is the first report 
showing that argon effects long-term cognition, suggesting it is worth pursuing into 
other models of injury. It is encouraging that argon treatment following 
hypoxia-ischemia increased the number of viable neurons to the same value as naïve 
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animals (Fig 2); we speculate that an argon induced upregulation of Bcl-2 increased 
cell survival (Fig 7).  
 
In previous studies helium has been shown to be protective in brain slices (12) and 
middle cerebral artery occlusion animal model (13); however we observed that 
helium had a detrimental effect on oxygen-glucose deprivation injury in cell culture 
(11). Herein helium significantly improved morphology and neurologic function from 
90 minutes of hypoxic-ischemia in line with a number of previous studies (12, 13, 24, 
25) however this protection was lost against the more severe insult of 120 minutes of 
hypoxic-ischemia. Simultaneously rats of helium group had lower body weight. The 
reason for this lower body weight is unclear, nonetheless this suggests that helium 
may exert some harmful as well as protective effects.  
 
It is of interest that argon and xenon both activate anti-apoptotic signaling shown by 
increased Bcl-2 and Bcl-xl levels respectively. Apoptotic neuronal cell death induced 
by ischemia/hypoxia results from activation of both the extrinsic and intrinsic 
pathways. In the process of activation of the intrinsic (mitochondrial) pathway, the 
increase in intracellular free calcium concentration, following excessive release of 
glutamate and activation of the NMDA receptor (26), triggers Bax translocation to 
and competition with Bcl-2 and other members of the Bcl-2 family in the 
mitochondria membrane evoking cytochrome C release to the cytosol (27-30). Bcl-2 
promotes cell survival, whereas Bax accelerates apoptotic cell death. The 
Bcl-2-related gene Bcl-x encodes 2 proteins: Bcl-xL which inhibits cell death, and 
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Bcl-xS which inhibits cell survival (31, 32). Our data suggests that the mechanism of 
neuroprotection afforded by noble gases may be due to the upregulation of genes 
and synthesis of the prosurvival proteins, Bcl-2 as well as Bcl-xL.  
 
Little is known about the direct molecular targets of the noble gases especially as the 
drugs may affect both intracellular and extracellular effectors. Xenon is known to 
antagonize NMDA receptors (33) and activate ATP-sensitive potassium channels (34) 
and the two-pore potassium channels (35). Argon may effect, gamma-aminobutyric 
acid type-A receptors (GABA) though further data is required to assess whether this 
is the mechanism for cytoprotection (36). Similarly the mechanisms of 
helium-induced organ-protection remain unclear. As a preconditioning agent, helium 
reduced infarct size via activating prosurvival kinases (24, 25) as well as mitochondrial 
ATP regulated potassium channel (24) and calcium-sensitive potassium channel (37), 
ultimately inhibiting mitochondrial permeability transition pore opening. 
Furthermore, the high thermal conductivity makes helium produce hypothermia in 
animals which is known to be a neuroprotective intervention (13) however in our 
model brain temperature was kept in the normal range. 
 
There are several limitations in our study. Notably in the rotarod test we only 
observed a trend to differences in neurological function and statistical significance 
was not achieved (p = 0.08). We suspect this is a type two statistical error due to lack 
of power to identify the effect especially given the multiple statistical tests required 
with so many groups. Unfortunately we are not able to repeat the experiment to 
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increase the statistical power. However we did observe a difference in the Morris 
water maze that more accurately measures neurocognitive function than the rotarod 
and is more likely a more sensitive test for detecting neurological impairment in this 
model. In concert, the neurological follow up data show that the noble gases 
provided functional neuroprotection. In addition, we cannot exclude that the lower 
body weight of helium group is attributable to poor maternal nurturing. However, 
from our experience, the variation between mother animals could not be expected 
to produce such a profound physiological difference. While all three noble gases 
proved protective in our model, we may not have been able to identify subtle 
differences between each gas in their neuroprotective potency. Only argon was able 
to restore viable cell counts to naïve levels, proving superior to helium and xenon, 
however we were unable to show that argon also improved neurological function 
above the other two gases. Nonetheless these data do provide rationale for testing 
argon in further models of neuronal injury and in combination with other 
neuroprotective therapeutics such as hypothermia in future studies. lastly, our 
conclusions could be compromised by the neurotoxic effect of isoflurane in the 
developing brain that has been well documented in the literature (38). However, 2% 
isoflurane exposed to the pups in our study was for less than 10 min which unlikely 
caused neuroapoptosis unless the exposure time reached up to 1 hour reported 
previously (39). 
 
In summary, this study showed that all three gases show effective neuroprotective 
properties in vivo. However while helium afforded morphological and behavioral 
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protection against moderate hypoxic-ischemic injury it was not protective against 
severe hypoxic-ischemia and showed detrimental effects on physiologic development. 
On the contrary both xenon and argon provided neuroprotection against both 
moderate and severe hypoxic-ischemic injury without gross adverse effects. Our 
observation that argon may be superior or at least equally efficacious to xenon is of 
interest as argon is significantly cheaper than xenon. In turn, this increases the 
breadth of potential applications for argon and the possibility of helping more 
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Titles and legends to figures: 
Figure 1. Experimental protocol. PND = postnatal day; HI = Hypoxic-ischemia.  
Figure 2: Hippocampal neuroprotection of noble gases against ischemia/hypoxia 
insult in rat neonates. Example microphotographs of the CA area of hippocampus 
taken from an animal with (A) no treatment (naïve), (B) nitrogen (control), (C) argon, 
(D) helium and (E) xenon, stained with 0.5% cresyl violet. (F) Argon, helium and 
xenon treatment significantly increased healthy cell number in the right CA area of 
hippocampus from 37 ± 8 in control group to 54 ± 6, 48 ± 5 and 47 ± 5 (P < 0.01) 
respectively. Mean ± SD (n = 5/group). RH in the top panel = right hippocampus; LH 
in the bottom panel = left hippocampus. *p < 0.05, **P<0.01 vs naïve; ++P< 0.01 vs 
control, “p<0.05 vs argon. 
Figure 3: Nissl stained of the coronal sections of brain 14 days after experiments. 
Representative brain micrograph from a rat treated with (A) nitrogen (control), (B) 
argon, (C) helium and (D) xenon. (E) Plot with mean data of the brain matter in the 
right healthy hemisphere against left hemisphere vs relative distance from Bregma. 
(F) Mean ± SD (n = 7/group). *P<0.05 vs control. 
Figure 4: Body weight of rats 14 days after experiments (120 min hypoxic insult) (A) 
and 31 days after experiments (90 min hypoxic insult) (B). Across all groups, 
hypoxic-ischemia for 120 min or hypoxic-ischemia for either 120 min or 90 min 
followed with helium treatment caused a significant decrease of body weight. Mean 
± SD (n = 6/group). **P<0.01 vs Naive.  
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Figure 5: Neurologic function assessed with Rotarod at the juvenile age. The time 
spent on rod at the speed 30 (A) and 50 (B) r.p.m. The data presented in a 
box-and-whisker plot (boxes are constructed with 25% and 75% confident intervals; 
the thick line in the box are medians; positive or negative bars are maximum or 
minimum individual values (n = 5/group).  
Figure 6: Neurocognitive behavior was determined by using Morris Water Maze at 
the juvenile age. (A) The mean learning and memory formation data against time 
course across all groups for five consecutive days. (B) Area under curve (AUC) 
derived from Figure A. (C) The mean swimming speed across all groups for executive 
five days. Mean ± SD (n = 6/group). D1-5 = Day 1-5. **p < 0.01 vs naïve; + p < 0.05, 
++p < 0.01 vs control.  
Figure 7: Argon, Helium or Xenon treatment induced changes of proapoptotic 
protein Bax and prosurvival proteins Bcl-xl and Bcl-2 expression in the left 
hippocampus. Bax (A), Bcl-xL (B) and Bcl-2 expression (C) after ischemia/hypoxia for 
90 min followed by 90 min gas exposure. Mean ± SD (n = 5/group). N = naïve; Con = 
control; Ar = argon; He = helium; Xe = xenon. *p <0.05,**p <0.01 vs naïve; +p < 0.05, 
++p < 0.01 vs control. 
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